Use of stearate in an inhalable formulation
US10022323B2 · kind B2 · utility
1Cited by
0References
5Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 28, 2014 |
| Grant date | Jul 17, 2018 |
| Priority date | — |
| Expiry date | Mar 28, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention concerns a method for making an inhaled pharmaceutical composition with improved powder handling properties comprising a stearate, a method of preparing such a composition, and the use of such a stearate in a composition when dispensed into a receptacle for use in a dry powder inhaler receptacle.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.